Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL

Kenneth Gordon, Kim Papp, Yves Poulin, Yihua Gu, Stephen Rozzo, Eric H. Sasso*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

145 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL'. Together they form a unique fingerprint.

Nursing and Health Professions

INIS

Pharmacology, Toxicology and Pharmaceutical Science